What Next: TBD | Tech, power, and the future
Technology
The diabetes medication Ozempic has exploded in popularity, particularly amongst those in Hollywood looking to lose a few extra pounds. But a silver bullet for weight loss leads to a number of questions: Is “buying weight loss” via injection somehow worse than diet and exercise? Are so many people buying and using this drug that people who need it for its intended purpose are missing out? What happened to body positivity?
Guest: Matthew Schneier, feature writer for New York Magazine.
Host: Lizzie O’Leary
If you enjoy this show, please consider signing up for Slate Plus. Slate Plus members get benefits like zero ads on any Slate podcast, bonus episodes of shows like Slow Burn and Dear Prudence—and you’ll be supporting the work we do here on What Next TBD. Sign up now at slate.com/whatnextplus to help support our work.
Learn more about your ad choices. Visit megaphone.fm/adchoices
The George Soros Succession
Reddit’s Rolling Blackouts
Are You Ready For A.I. Generated Actors?
Is Crypto Toast?
Tech’s Newest Trillion Dollar Company
When Your Childhood Was Their Content
The Trouble With TikTok Songs
Tweetering on the Glass Cliff
A Tipping Point for Digital Tipping
Why Sports Are All in on Betting
Space After NASA
Who’s Afraid of A.I.?
What's Going on at Meta?
What the Writers' Strike Is Really About
Is Your Uber Drivers' Pay Rigged?
Stephen King Is Just as Confused About Blue Checks as You Are
"Crap Apps": Why Weather Apps Suck
Will A.I. Close Off the Internet?
Will Banning Social Media Help Kids?
How Gamers Leaked Classified Pentagon Docs
Create your
podcast in
minutes
It is Free
Slow Burn
Slate Debates
What Next | Daily News and Analysis
Decoder Ring
Amicus With Dahlia Lithwick | Law, justice, and the courts